Illumina Valuation
| ILMN Stock | USD 136.99 5.31 4.03% |
At this time, the firm appears to be undervalued. Illumina retains a regular Real Value of $162.14 per share. The prevalent price of the firm is $136.99. Our model calculates the value of Illumina from evaluating the firm fundamentals such as Return On Asset of 0.0262, current valuation of 23.15 B, and Return On Equity of -0.4 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Illumina's valuation include:
Price Book 10.0758 | Enterprise Value 23.1 B | Enterprise Value Ebitda 51.8755 | Price Sales 4.7573 | Forward PE 30.3951 |
Undervalued
Today
Please note that Illumina's price fluctuation is very steady at this time. Calculation of the real value of Illumina is based on 3 months time horizon. Increasing Illumina's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Illumina is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Illumina Stock. However, Illumina's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 136.99 | Real 162.14 | Target 186.44 | Hype 136.66 | Naive 125.16 |
The intrinsic value of Illumina's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Illumina's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Illumina helps investors to forecast how Illumina stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Illumina more accurately as focusing exclusively on Illumina's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Illumina's intrinsic value based on its ongoing forecasts of Illumina's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Illumina's closest peers.
Illumina Cash |
|
Illumina Valuation Trend
Knowing Illumina's actual value is paramount for traders when making sound investment determinations. Using both Illumina's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Illumina Revenue by Product
Illumina Total Value Analysis
Illumina is currently expected to have valuation of 23.15 B with market capitalization of 20.88 B, debt of 2.26 B, and cash on hands of 2.01 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Illumina fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.15 B | 20.88 B | 2.26 B | 2.01 B |
Illumina Investor Information
About 95.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.63. Illumina recorded a loss per share of 9.98. The entity had not issued any dividends in recent years. The firm had 1028:1000 split on the 25th of June 2024. Based on the key measurements obtained from Illumina's financial statements, Illumina is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Illumina Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Illumina has an asset utilization ratio of 44.55 percent. This suggests that the Company is making $0.45 for each dollar of assets. An increasing asset utilization means that Illumina is more efficient with each dollar of assets it utilizes for everyday operations.Illumina Ownership Allocation
Illumina has a total of 158.6 Million outstanding shares. The majority of Illumina outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Illumina to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Illumina. Please pay attention to any change in the institutional holdings of Illumina as this could imply that something significant has changed or is about to change at the company. On October 2, 2024, Representative Michael C Burgess of US Congress acquired $15k to $50k worth of Illumina's common stock.Illumina Profitability Analysis
The company reported the previous year's revenue of 4.5 B. Net Loss for the year was (1.16 B) with profit before overhead, payroll, taxes, and interest of 3.15 B.About Illumina Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Illumina. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Illumina based exclusively on its fundamental and basic technical indicators. By analyzing Illumina's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Illumina's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Illumina. We calculate exposure to Illumina's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Illumina's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.7 B | 2.9 B | |
| Pretax Profit Margin | (0.25) | (0.26) | |
| Operating Profit Margin | (0.24) | (0.25) | |
| Net Loss | (0.26) | (0.27) | |
| Gross Profit Margin | 0.61 | 0.79 |
Illumina Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 158 M | |
| Quarterly Earnings Growth Y O Y | -0.965 | |
| Forward Price Earnings | 30.3951 |
Illumina Current Valuation Indicators
Illumina's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Illumina's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Illumina, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Illumina's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Illumina's worth.When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (9.98) | Revenue Per Share 27.654 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0262 |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.